Additive antioxidative effect of hormone replacement therapy combined with a statin

Clinical and Experimental Obstetrics and Gynecology

Volumn 27, Issue 3-4, 2000, Pages 179-181

  Seeger, H ^a   Wallwiener, D ^a   Mueck, A O ^a  

^a UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

Author keywords

Estradiol; Fluvastatin; LDL oxidation; Norethisterone acetate

Indexed keywords

COPPER CHLORIDE; ESTRADIOL; FLUINDOSTATIN; LOW DENSITY LIPOPROTEIN; NORETHISTERONE ACETATE;

ANTIOXIDANT ACTIVITY; ARTICLE; ATHEROSCLEROSIS; CONTROLLED STUDY; DRUG EFFECT; DRUG POTENTIATION; ESTROGEN THERAPY; FEMALE; HORMONE SUBSTITUTION; HUMAN; LIPID OXIDATION; SERUM; SPECTROMETRY;

ANTICHOLESTEREMIC AGENTS; ANTIOXIDANTS; ARTERIOSCLEROSIS; DRUG INTERACTIONS; ESTRADIOL; ESTROGEN REPLACEMENT THERAPY; FATTY ACIDS, MONOUNSATURATED; FEMALE; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; INDOLES; LIPID PEROXIDATION; LIPOPROTEINS, LDL; NORETHINDRONE; POSTMENOPAUSE;

EID: 0034480603     PISSN: 03906663     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Cholesterol lowering with statin drugs, risk of stroke, and total mortality
2. Cardiovascular mortality in noncontracceptive use of estrogen in women: Results from the Lipid Research Clinics Program Follow-up Study
3. Statins do more than just lower cholesterol
4. The protective effects of estrogen on the cardiovascular system
5. Fluvastatin increases prostacyclin and decreases endothelin production by human umbilical vein endothelial cells
6. An in vitro study of the hydroxyl radical scavenging property of fluvastatin, an HMG-CoA reductase inhibitor
7. Non-genomic action of estrogens: Estrogens as antioxidants
8. Estrogen and progestin compared with simvastatin for hypercholesterolemia in postmenopausal women
9. Individual and combined effects of progestin therapy and lovastatin on lipids and flow-mediated vasodilation in postmenopausal women with coronary artery disease
10. Hormone replacement therapy and simvastatin in the therapy of hypercholesterolemic postmenopausal women
11. Effect of fluvastatin and estradiol on the production of prostacyclin and endothelin in human umbilical vein endothelial cells
12. Fluvastatin combined with 17β-estradiol: Effect on the oxidation of human low density lipoprotein
13. Continuous monitoring of in vitro oxidation of human low density lipoprorein
14. Oxidative modification of LDL and atherogenesis
15. Effects of native and oxidized low density lipoproteins on formation and inactivation of endothelium-derived relaxing factor
16. Stimulation of endothelin-1 release by low density and very low density lipoproteins in cultured human endothelial cells
17. Inhibition of hypercholesteremia-induced athersoclerosis in the nonhuman primate by probucol. I. Is the extent of atherosclerosis related to resistance of LDL to oxidation
18. Randomised controlled trial of vitamin E in patients with coronary artery disease: Cambridge Heart Antioxidant Study (CHAOS)
19. Protective effect of fluvastatin sodium (XU-62-320), a 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitor, on oxidative modification of human low-density lipoprotein in vitro
20. Estradiol inhibits LDL oxidation: Do the progestins medroxyprogesterone acetate and norethisterone acetate influence this effect?
21. Fluvastatin and low-density lipoprotein oxidation in hypercholestermic renal transplant patients
22. Effects of fluvastatin therapy on lipids, antioxidants, oxidation of low density lipoproteins and trace metals
23. Oestrogen and inhibition of oxidation of low-density lipoproteins in postmenopausal women
24. Effect of combined 17 beta-estradiol and vitamin E on low-density lipoprotein oxidation in postmenopausal women
25. Are the antioxidative effects of 17 beta-estradiol modified by concomitant administration of a progestin?
26. Cardioprotective effects of individual conjugated equine estrogens through possible modulation of insulin resistance and oxidation of low-density lipoprotein
27. Effects of estrogen on susceptibility to oxidation of low-density and high-density lipoprotein in postmenopausal women
28. The effect of sequential three-monthly hormone replacement therapy on several cardiovascular risk estimators in postmenopausal women
29. The effect of hormone replacement therapy on the oxidation of low-density lipoprotein in postmenopausal women
30. Combined oestrogen-progestogen replacement therapy does not inhibit low-density lipoprotein oxidation in postmenopausal women